Key facts
- This page summarizes Wayne Markowitz's Form 4 filing for Edwards Lifesciences Corp (EW).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Dec 2024, 16:56.
Wayne Markowitz - 06 Dec 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)
- Reporting relationship
- GM & SVP, Surgical
- Issuer ticker
- EW
- Reported as of
- 06 Dec 2024
- Net transaction value
- -$42,716
- SEC form
- 4
- Accepted by SEC
- 06 Dec 2024, 16:56:45 UTC
- Prior SEC filing
- 16 Sep 2024
- Next SEC filing
- 09 May 2025
- Source filing
- View source filing
- Reporting owner signature
- Linda J. Park, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Wayne Markowitz filed Form 4 for Edwards Lifesciences Corp (EW) on 06 Dec 2024.
Change
- Previous filing in this sequence was filed on 16 Sep 2024.
- Current net transaction value: -$42,716.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EW
transaction
Common Stock
Sale
- Transaction value
- $42,716
- Shares
- -583
- Change %
- -5.8%
- Price
- $73.27
- Shares after
- 9,494
- Date
- 06 Dec 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.